Company Profile
Intellia Therapuetics
Company Overview
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.
Company History
Website
http://www.intelliatx.com
Headquarters
Cambridge, Massachusetts
Year founded
2014
Company type
Public Company
Company size
51-200 employees
Benefits
We offer a very engaging work environment and competitive benefit programs. Our benefits include:
First-class salary and bonus compensation
Excellent equity award program
Superior health care benefits, including:
90% employer-paid, industry leading medical, dental benefits
100% employer-paid vision benefits
401k with competitive match
Education reimbursement
Opportunity to unleash your skills, ideas and passion to change the world
Flexible work schedules, including summer hours
Subsidized parking, as well as EZ Ride access for commuters
Immigration assistance and green card sponsorship
On-site fitness center
Discount membership at local gyms
Well-stocked kitchens
Game nights and other social activities